首页|铝碳酸镁联合四联疗法治疗幽门螺杆菌感染十二指肠溃疡患者的效果

铝碳酸镁联合四联疗法治疗幽门螺杆菌感染十二指肠溃疡患者的效果

扫码查看
目的:观察铝碳酸镁联合四联疗法治疗幽门螺杆菌(Hp)感染十二指肠溃疡(DU)患者的效果.方法:选取 2020 年 1 月至 2021 年 2 月该院收治的 80 例Hp感染DU患者进行前瞻性研究,按照随机数字表法将其分为对照组和观察组各 40 例.对照组采用四联疗法治疗,观察组在对照组基础上联合铝碳酸镁治疗,两组均连续治疗4周.比较两组临床疗效,治疗前后胃肠激素指标[胃泌素(GAS)、肾上腺髓质素(AM)、胃动素(MTL)、生长抑素(SS)、降钙素基因相关肽(CGRP)]水平、炎性因子[白细胞介素-1β(IL-1β)、白细胞介素-18(IL-18)]水平,Hp根除率和不良反应发生率.结果:观察组治疗总有效率为95.00%(38/40),高于对照组的80.00%(32/40),差异有统计学意义(P<0.05);治疗后,观察组GAS、AM、MTL水平均低于对照组,SS、CGRP水平均高于对照组,差异有统计学意义(P<0.05);治疗后,观察组IL-1β、IL-18 水平均低于对照组,差异有统计学意义(P<0.05);观察组Hp根除率为 92.50%(37/40),高于对照组的 72.50%(29/40),差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:铝碳酸镁联合四联疗法治疗Hp感染DU患者可提高治疗总有效率和Hp根除率,改善胃肠激素指标水平,降低炎性因子水平,效果优于单纯四联疗法治疗.
Effects of Hydrotalcite combined with quadruple therapy on patients with duodenal ulcer and Helicobacter pylori infection
Objective:To observe effects of Hydrotalcite combined with quadruple therapy on patients with duodenal ulcer(DU)and Helicobacter pylori(Hp)infection.Methods:A prospective study was conducted on 80 patients with DU and Hp infection admitted to the hospital from January 2020 to February 2021.They were divided into control group and observation group according to the random number table method,40 cases in each.The control group was treated with quadruple therapy,while the observation group was treated with Hydrotalcite on the basis of that of the control group.Both groups were treated for 4 weeks.The clinical efficacy,the levels of gastrointestinal hormone indexes[gastrin(GAS),adrenomedullin(AM),motilin(MTL),somatostatin(SS),calcitonin gene-related peptide(CGRP)]and the inflammatory factors[interleukin-1β(IL-1β),interleukin-18(IL-18)]before and after the treatment,the Hp eradication rate,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of the observation group was 95.00% (38/40),which was higher than 80.00% (32/40)of the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of GAS,AM and MTL in the observation group were lower than those in the control group,the levels of SS and CGRP were higher than those in the control group,and the differences were statistically significant(P<0.05).After the treatment,the levels of IL-1β and IL-18 in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).The Hp eradication rate in the observation group was 92.50% (37/40),which was higher than 72.50% (29/40)in the control group,and the difference was statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Hydrotalcite combined with quadruple therapy in the treatment of the DU patients with Hp infection can improve the total effective rate of treatment and the Hp eradication rate,improve the levels of gastrointestinal hormones,and reduce the levels of inflammatory factors.Moreover,it is superior to single quadruple therapy.

Duodenal ulcerHelicobacter pyloriInfectionHydrotalcitePantoprazoleQuadruple therapyGastrointestinal hormone

张玉、程涛、李志伟

展开 >

商丘市中医院脾胃肝胆科,河南 商丘 476000

十二指肠溃疡 幽门螺杆菌 感染 铝碳酸镁 泮托拉唑 四联疗法 胃肠激素

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(4)
  • 13